Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1984 1
1988 1
1993 2
2003 1
2008 2
2010 2
2011 3
2012 3
2013 4
2014 5
2015 3
2016 5
2017 1
2018 4
2019 5
2020 4
2021 6
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
Neoantigens elicit T cell responses in breast cancer.
Morisaki T, Kubo M, Umebayashi M, Yew PY, Yoshimura S, Park JH, Kiyotani K, Kai M, Yamada M, Oda Y, Nakamura Y, Morisaki T, Nakamura M. Morisaki T, et al. Among authors: umebayashi m. Sci Rep. 2021 Jun 30;11(1):13590. doi: 10.1038/s41598-021-91358-1. Sci Rep. 2021. PMID: 34193879 Free PMC article. Clinical Trial.
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer.
Oyama Y, Nagao S, Na L, Yanai K, Umebayashi M, Nakamura K, Nagai S, Fujimura A, Yamasaki A, Nakayama K, Morisaki T, Onishi H. Oyama Y, et al. Among authors: umebayashi m. Anticancer Res. 2021 Aug;41(8):4047-4052. doi: 10.21873/anticanres.15205. Anticancer Res. 2021. PMID: 34281873
A Chemogenetic Approach for the Optical Monitoring of Voltage in Neurons.
Sundukova M, Prifti E, Bucci A, Kirillova K, Serrao J, Reymond L, Umebayashi M, Hovius R, Riezman H, Johnsson K, Heppenstall PA. Sundukova M, et al. Among authors: umebayashi m. Angew Chem Int Ed Engl. 2019 Feb 18;58(8):2341-2344. doi: 10.1002/anie.201812967. Epub 2019 Jan 25. Angew Chem Int Ed Engl. 2019. PMID: 30569539 Free PMC article.
Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis.
Morisaki T, Morisaki T, Kubo M, Onishi H, Hirano T, Morisaki S, Eto M, Monji K, Takeuchi A, Nakagawa S, Tanaka H, Koya N, Umebayashi M, Tsujimura K, Yew PY, Yoshimura S, Kiyotani K, Nakamura Y. Morisaki T, et al. Among authors: umebayashi m. Anticancer Res. 2021 Aug;41(8):4101-4115. doi: 10.21873/anticanres.15213. Anticancer Res. 2021. PMID: 34281881
Mutant KRAS Promotes NKG2D+ T Cell Infiltration and CD155 Dependent Immune Evasion.
Nishi K, Ishikura S, Umebayashi M, Morisaki T, Inozume T, Kinugasa T, Aoki M, Nimura S, Swain A, Yoshida Y, Hasegawa S, Nabeshima K, Sakata T, Shirasawa S, Tsunoda T. Nishi K, et al. Among authors: umebayashi m. Anticancer Res. 2020 Aug;40(8):4663-4674. doi: 10.21873/anticanres.14465. Anticancer Res. 2020. PMID: 32727790
PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor.
Koga S, Onishi H, Masuda S, Fujimura A, Ichimiya S, Nakayama K, Imaizumi A, Nishiyama K, Kojima M, Miyoshi K, Nakamura K, Umebayashi M, Morisaki T, Nakamura M. Koga S, et al. Among authors: umebayashi m. Transl Oncol. 2021 Sep;14(9):101152. doi: 10.1016/j.tranon.2021.101152. Epub 2021 Jun 13. Transl Oncol. 2021. PMID: 34134073 Free PMC article.
52 results